Chronic heart failure
351 results
250 - 349
Antioxidants for adults with chronic kidney disease
SBP of 120 instead of 140 in nondiabetic, high-risk elderly leads to significant benefits and some harms (SPRINT)
Haemoptysis - Immunosuppressive T‐cell antibody induction for heart transplant recipients
- Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non‐diabetic chronic kidney disease
- Sotrovimab reduces the likelihood of hospitalization in at-risk outpatients with mild to moderate COVID-19 (NNT = 16)
- Higher risk of bleeding events associated with concomitant use of amiodarone and direct oral anticoagulants
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
- aDrugs commonly causing poisonings
- Blood pressure targets in adults with hypertension
- Ipratropium associated with increase risk of CV events
- No decrease in all-cause mortality with LMWH for VTE prophylaxis in hospitalized medical patients
- Osteoporosis
- Respiratory failure
- Apixaban slightly more effective and safe than warfarin, but more expensive
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- Transfusion thresholds for guiding allogeneic red blood cell transfusion
- Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults
- Interactive telemedicine: effects on professional practice and health care outcomes
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Lower costs and healthcare utilization with hospital care at home
- Interventions for weight loss in people with chronic kidney disease who are overweight or obese
- Antidepressants for depression in physical illness
- Diabetic kidney disease (diabetic nephropathy)
- SGLT2 inhibitors reduce cardiovascular mortality but benefit is modest, even in patients with established heart disease (NNT = 200 for 3 years)
- Colchicine reduces myocardial infarction and revascularization in patients with established coronary disease (LoDoCo2)
- Acute abdomen in the adult
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
- The most common types of acquired adult valvular heart disease and associated murmurs
- Early referral to specialist nephrology services for preventing the progression to end‐stage kidney disease
- Guidelines for obstructive sleep apnea and insomnia from the US Departments of Defense and Veteran Affairs
- High-dose influenza vaccine no more effective than the standard dose for adults with high-risk cardiovascular disease
- Two-day oral dexamethasone course effective in treatment of mild asthma exacerbation
- Patient navigators reduce readmission rates for high-risk older patients
- Wells score not helpful in hospitalized patients with suspected DVT
- Water for preventing urinary stones
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Treatment of chronic renal failure
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Secondary hypertension
- Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
- Cirrhosis of the liver
- Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk
- Acute coronary syndrome
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
- Normal and abnormal growth in childhood
- Effect of cyclosporine on blood pressure: Cochrane systematic review
- Automated telephone communication systems for preventive healthcare and management of long-term conditions: Cochrane systematic review
- Personalised care planning for adults with chronic or long‐term health conditions
- Clinical, functional, and demographic factors predict 10-year mortality in adults older than 50
- Polycystic kidney disease
- Guanylate cyclase stimulators for pulmonary hypertension
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis
- Overview of new ACC/AHA lipid guidelines: here we go again
- Transmyocardial laser revascularization versus medical therapy for refractory angina: Cochrane systematic review
- Trypanocidal drugs for late‐stage, symptomatic Chagas disease (Trypanosoma cruzi infection)
- Interventions for chronic non-hypovolaemic hypotonic hyponatraemia: Cochrane systematic review
- Education programmes for people with chronic kidney disease and diabetes
- Palliative treatment
- Dronedarone prevents AF recurrence but effect on symptoms unknown
- Screening strategies for hypertension
- Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
- Inspiratory muscle training for asthma
- Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation
- Influenza
- Hyponatraemia
- Iron therapy in anaemic adults without chronic kidney disease: Cochrane systematic review
- Temperature-induced skin disorders
- Oral care measures for preventing nursing home‐acquired pneumonia
- Prolonged diarrhoea in adults
- Anticonvulsants for fibromyalgia: Cochrane systematic review
- Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants
- Effectiveness and cost‐effectiveness of home palliative care services for adults with advanced illness and their caregivers
- Implantable cardiac defibrillators for people with non‐ischaemic cardiomyopathy
- Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
- Transfusion thresholds for guiding red blood cell transfusion
- Community care navigation intervention for people who are at risk of unplanned hospital presentations
- Chronic obstructive pulmonary disease (COPD)
- Prehospital emergency care
- Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications
- Colchicine for the primary prevention of cardiovascular events
- Interventions for fatigue and weight loss in adults with advanced progressive illness
- Vaccinations
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
- Iron therapy for preoperative anaemia
- Withdrawal of antihypertensive drugs in older people